TY - JOUR
T1 - Essential fatty acid preparation improves biochemical and cognitive functions in experimental allergic encephalomyelitis rats
AU - Yehuda, Shlomo
AU - Rabinovitz, Sharon
AU - Mostofsky, David I.
AU - Huberman, Moshe
AU - Sredni, Benjamin
PY - 1997/9
Y1 - 1997/9
N2 - This study examined the possible effects of a novel mixture of fatty acids, SR-3 (a specific ratio of a-linolenic acids), on brain biochemistry and on learning deficits induced by injection of an agent that induces experimental allergic encephalomyelitis. Treatment with SR-3 caused a decrease in myelin and changes in the fatty acid profile of brain synaptosomes, and a learning deficit. Eighteen days of treatment with SR-3 reversed the biochemical and learning deficit significantly, but did not restore them to normal levels. We propose that, most probably, the main action of SR-3 is the modulation of the cholesterol level, which in turn causes the modulation of the fatty acid profile and enhances learning by allowing improved neuronal communication.
AB - This study examined the possible effects of a novel mixture of fatty acids, SR-3 (a specific ratio of a-linolenic acids), on brain biochemistry and on learning deficits induced by injection of an agent that induces experimental allergic encephalomyelitis. Treatment with SR-3 caused a decrease in myelin and changes in the fatty acid profile of brain synaptosomes, and a learning deficit. Eighteen days of treatment with SR-3 reversed the biochemical and learning deficit significantly, but did not restore them to normal levels. We propose that, most probably, the main action of SR-3 is the modulation of the cholesterol level, which in turn causes the modulation of the fatty acid profile and enhances learning by allowing improved neuronal communication.
KW - Experimental allergic encephalomyelitis
KW - Fatty acid
KW - Linolenic acid
KW - Multiple sclerosis
KW - α-Linolenic acid
UR - http://www.scopus.com/inward/record.url?scp=0030951266&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(97)83022-1
DO - 10.1016/S0014-2999(97)83022-1
M3 - Article
C2 - 9203563
AN - SCOPUS:0030951266
SN - 0014-2999
VL - 328
SP - 23
EP - 29
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -